Impact of TP53 Mutation Status in Elderly AML Patients when Adding All-Trans Retinoic Acid or Valproic Acid to Decitabine.
Helena Bresser,Claudia Schmoor,Olga Grishina,Dietmar Pfeifer,Johanna Thomas,Usama-Ur Rehman,Martina Crysandt,Edgar Jost,Felicitas Thol,Michael Heuser,Katharina S. Goetze,Richard F. Schlenk,Helmut R. Salih,Marcus M. Schittenhelm,Gerhard Heil,Carsten Schwaenen,Carsten Mueller-Tidow,Wolfram Brugger,Andrea Kuendgen,Maike de Wit,Aristoteles Giagounidis,Sebastian Scholl,Andreas Neubauer,Juergen Krauter,Gesine Bug,Annette M. May,Ralph Waesch,Justus Duyster,Konstanze Doehner,Arnold Ganser,Hartmut Doehner,Bjoern Hackanson, Heiko Becker,Michael Luebbert EUROPEAN JOURNAL OF HAEMATOLOGY（2025）
Key words
AML,ATRA,epigenetics,HMA,TP53
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper